Literature DB >> 16331006

The treatment of acetabular bone defects with an associated pelvic discontinuity.

Wayne G Paprosky1, Michael O'Rourke, Scott M Sporer.   

Abstract

UNLABELLED: Pelvic discontinuity is encountered frequently during acetabular revision in patients with severe acetabular bone loss. Prompt recognition of the discontinuity and appropriate intraoperative treatment are essential for a successful clinical outcome. The treatment of the discontinuity is dependent on the remaining host bone, the potential for healing of the discontinuity, and the potential for biologic ingrowth of acetabular components. If healing potential of the discontinuity exists, the discontinuity should be treated in compression with a posterior column plate and structural allograft or with the use of trabecular metal acting as an internal plate. If healing potential for the discontinuity does not exist, the discontinuity should be bridged and treated in distraction with an acetabular transplant supported with a cage, a trabecular metal component with trabecular metal augmentation, or with the use of a custom triflange implant. LEVEL OF EVIDENCE: Therapeutic study, Level III-1 (case-control study). See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2005        PMID: 16331006     DOI: 10.1097/01.blo.0000194311.20901.f9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  21 in total

1.  Hip painful prosthesis: surgical view.

Authors:  Antonio Spinarelli; Vittorio Patella; Vito Conserva; Giovanni Vicenti; Vito Pesce; Silvio Patella
Journal:  Clin Cases Miner Bone Metab       Date:  2011-05

2.  Pelvic discontinuity treated with custom triflange component: a reliable option.

Authors:  Michael J Taunton; Thomas K Fehring; Paul Edwards; Thomas Bernasek; Ginger E Holt; Michael J Christie
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

Review 3.  Treatment algorithm of acetabular periprosthetic fractures.

Authors:  Paul Simon; Philipp von Roth; Carsten Perka
Journal:  Int Orthop       Date:  2015-08-30       Impact factor: 3.075

Review 4.  [Acetabular defect reconstruction in revision surgery of the hip. Autologous, homologous or metal?].

Authors:  S Gravius; G Pagenstert; O Weber; N Kraska; H Röhrig; D C Wirtz
Journal:  Orthopade       Date:  2009-08       Impact factor: 1.087

5.  Validation of the Charlson comorbidity index in patients undergoing revision total hip arthroplasty.

Authors:  Jan Schmolders; Max J Friedrich; Robert Michel; Andreas C Strauss; Matthias D Wimmer; Thomas M Randau; Peter H Pennekamp; Dieter C Wirtz; Sascha Gravius
Journal:  Int Orthop       Date:  2015-06-24       Impact factor: 3.075

6.  Are custom triflange acetabular components effective for reconstruction of catastrophic bone loss?

Authors:  Carl C Berasi; Keith R Berend; Joanne B Adams; Erin L Ruh; Adolph V Lombardi
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

7.  Smoking may be a harbinger of early failure with ultraporous metal acetabular reconstruction.

Authors:  Adolph V Lombardi; Keith R Berend; Joanne B Adams; Ryan C Jefferson; Michael A Sneller
Journal:  Clin Orthop Relat Res       Date:  2013-02       Impact factor: 4.176

8.  Limitations of conventional radiographs in the assessment of acetabular defects following total hip arthroplasty.

Authors:  Oleg Safir; Cliff Lin; Yona Kosashvili; Ian P Mayne; Allan E Gross; David Backstein
Journal:  Can J Surg       Date:  2012-12       Impact factor: 2.089

9.  Acetabular distraction: an alternative for severe defects with chronic pelvic discontinuity?

Authors:  Scott M Sporer; John J Bottros; Jonah B Hulst; Vamsi K Kancherla; Mario Moric; Wayne G Paprosky
Journal:  Clin Orthop Relat Res       Date:  2012-11       Impact factor: 4.176

10.  Salvage of failed acetabular cages by nonbuttressed trabecular metal cups.

Authors:  Yona Kosashvili; Oleg Safir; David Backstein; Dror Lakstein; Allan E Gross
Journal:  Clin Orthop Relat Res       Date:  2009-06-20       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.